|
1. |
Induction of tolerance to heart transplants by simultaneous cotransplantation of donor kidneys may depend on a radiation-sensitive renal-cell population |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 625-631
Joshua Mezrich,
Kazuhiko Yamada,
Richard Lee,
Kwabena Mawulawde,
Louis Benjamin,
Margaret Schwarze,
Michaella Maloney,
Hannah Amoah,
Stuart Houser,
David Sachs,
Joren Madsen,
Preview
|
PDF (583KB)
|
|
摘要:
Background.To determine the mechanism by which cotransplantation of a donor kidney and heart allograft induces tolerance to both organs in miniature swine, we examined the renal elements responsible for tolerance induction.Methods.Recipients received 12 days of cyclosporine, and transplants were performed across a major histocompatibility complex (MHC) class I mismatch. Group 1 animals received heart transplants (n=5); group 2 animals received heart and kidney allografts with no other manipulation (n=4); group 3 animals received heart transplants and donor-specific renal parenchymal cells (n=4); group 4 animals received heart and kidney allografts from lethally irradiated donors (n=7); group 5 animals received irradiated hearts and nonirradiated kidneys (n=2); group 6 animals received nonirradiated hearts and peripheral blood leukocytes from swine MHC matched to recipients and becoming tolerant to donor antigen (n=2); group 7 animals received nonirradiated hearts and donor-specific peripheral blood monocyte cells (PBMC) (n=2).Results.Animals in group 1 developed vasculopathy and fulminant rejection by day 55. Animals in group 2 never developed vascular lesions. Parenchymal kidney cell infusion (group 3) did not prolong cardiac survival. Animals in group 4 developed arteriopathy by postoperative day (POD) 28. Group 5 recipients accepted allografts without vascular lesions. Adoptive transfer of leukocytes from tolerant swine (group 6) prolonged cardiac graft survival as much as 123 days, whereas donor PBMC infusion (group 7) did not affect cardiac survival or development of arteriopathy.Conclusions.Radiosensitive elements in kidney allograft may be responsible for tolerance induction and prevention of chronic vascular lesions in recipients of simultaneous heart and kidney allografts.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
2. |
Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1 |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 631-636
S. Jordan,
A. Vo,
S. Bunnapradist,
M. Toyoda,
A. Peng,
D. Puliyanda,
E. Kamil,
D. Tyan,
Preview
|
PDF (252KB)
|
|
摘要:
Background.Sensitization to human leukocyte antigens (HLA) is a significant barrier to transplantation. Currently, no proven therapy exists to improve access to transplantation for highly sensitized patients. Here, we report a novel approach using intravenous immune globulin to modulate anti-HLA antibody and improve the chances for successful transplantation.Patients and methods.Forty-five highly HLA-sensitized patients presented as candidates for living-donor kidney transplantation (n=28), cadaveric kidney transplantation (n=15), or heart transplantation (n=2). All patients had a positive CDC crossmatch (CMX) with their donors. In living-donor recipients, intravenous immune globulin (IVIG) was added to the CMX evaluation to determine whether blocking antibodies present in IVIG could inhibit cytotoxicity. For those who showed in vitro inhibition with IVIG (n=26), IVIG was administered (usually as a single dose, 2 g/kg) and the CDC CMX was repeated against the prospective donor immediately after IVIG infusion. If negative, the patient underwent transplantation with their living-donor kidney within 24 to 72 hr. A similar but modified protocol was performed for cadaver donor candidates, all of whom were highly sensitized and had had CMX positivity with multiple donors, negating transplantation. Reductions in CMX positivity, posttransplantation serum creatinine level, number and severity of rejection episodes, and patient and graft survival rates were determined.Results.Forty-two patients underwent transplantation. IVIG treatment completely abrogated the donor-specific CMXs in 35 of 42 patients. In the remaining 7 patients, the CDC CMX was inhibited, but flow cytometry CMXs remained positive. A total of 13 (31%) of 42 recipients developed rejection episodes 3 to 49 days after transplantation. Three grafts (7%) were lost to rejection. Mean serum creatinine level at 24 months was 1.4±0.4 mg/dL. Patient and graft survival rates were 97.6% and 89.1%, respectively, at 24 months.Conclusions.The in vitro IVIG CMX technique predicts the ability of IVIG to reduce anti-HLA antibody levels in highly sensitized patients. Subsequent in vivo IVIG treatment of responders eliminates the positive CDC CMX and allows for successful transplantation. Thus a positive CMX result is not necessarily a contraindication for transplantation and allows access to transplantation for patients for whom it was previously contraindicated.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
3. |
Isolated intestinal transplantation: proof of clinical efficacy |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 636-640
Thomas Fishbein,
Stuart Kaufman,
Sander Florman,
Gabriel Gondolesi,
Thomas Schiano,
Leona Kim-Schluger,
Margaret Magid,
Noam Harpaz,
Alan Tschernia,
Andrew Leibowitz,
Neal LeLeiko,
Preview
|
PDF (387KB)
|
|
摘要:
Background and Aims.Isolated intestinal transplantation has been limited by poor patient and graft survival. If high survival could be achieved and if parenteral nutrition-associated liver disease were reversible, this procedure could be more widely applied, with early liver dysfunction indicating the need for transplant evaluation.Methods.Twenty-six patients who had failed parenteral nutrition received 28 isolated intestinal transplants. We analyzed patient and graft survival, the effect of sirolimus on the severity and frequency of rejection, and the reversibility of liver dysfunction after transplant.Results.Three-year actuarial patient and primary graft survival were 88% and 71%, respectively. Two patients underwent successful retransplants. Twenty-two patients are alive at a mean of 21±15 (median 18; range 3–51) months. Actuarial survival with freedom from parenteral support is 81% at 3 years (21 of 26 patients). Actuarial freedom from parenteral support among survivors is 95.5% at 3 years (21 of 22 patients). Early rejection was less frequent with sirolimus (34% vs. 70% without sirolimus) (P=0.007). Moderate and severe rejection was less frequent with sirolimus (1/11 episodes vs. 9/17 episodes without sirolimus) (P=0.05). No grafts were lost after introduction of sirolimus. In all four patients with advanced liver dysfunction, fibrosis and cholestasis regressed within 1 year.Conclusions.High patient survival and parenteral nutrition-free survival can be achieved after isolated intestinal transplantation. Sirolimus treatment has eliminated graft loss. Parenteral nutrition-associated liver disease is reversible with intestinal transplantation. Refractory liver dysfunction in patients receiving parenteral nutrition should prompt consideration for isolated intestinal transplantation.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
4. |
Living-Donor Liver Transplantation with Monosegments. |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 641-642
Chi-Leung Liu,
Sheung-Tat Fan,
Preview
|
PDF (98KB)
|
|
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
5. |
Impaired Tubulointerstitial Expression of Endothelin-1 and Nitric Oxide Isoforms in Donor Kidney Biopsies with Postischemic Acute Renal Failure. |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 642-643
Leendert Paul,
Preview
|
PDF (89KB)
|
|
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
6. |
LF 15–0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 644-650
Dejun Zhou,
Catherine O’Brien,
Jeffrey Shum,
Bertha Garcia,
Weiping Min,
Anthony Jevnikar,
Patrick Dutartre,
Robert Zhong,
Preview
|
PDF (271KB)
|
|
摘要:
Background.LF 15–0195 (LF) is a new analogue of 15-deoxyspergualin (DSG) that is less toxic and more potent than DSG. The present study was undertaken to determine (1) the dose response of LF monotherapy, (2) its ability to induce tolerance, and (3) its interaction with cyclosporine (CsA), FK 506 (FK), and rapamycin (RAPA).Methods.Varying doses of LF were administered to determine dose-dependent effects on graft survival in a C57BL/6 to BALB/c heterotopic heart allograft mouse model. Transplanting-donor and third-party skin grafts into long-term survivors were used to assess the tolerance status. CsA, FK, and RAPA were combined with LF to determine their interactive effects on graft survival.Results.The efficacy and toxicity of LF was dose dependent. High-dose LF monotherapy (>2 mg/kg) induced donor-specific operational tolerance, but it was associated with high mortality. Simultaneous administration of high-dose calcineurin inhibitors (CsA FK) prevented tolerance induced by LF. In contrast, a short course of LF combined with a subtherapeutic dose of CsA FK achieved indefinite survival of C57/BL6 cardiac allografts. RAPA and LF had a synergistic effect in induction of tolerance.Conclusions.The efficacy and toxicity of LF were dose dependent. A short course of LF significantly reduced the requirement of CsA or FK to prevent rejection. RAPA and LF had synergy in induction of tolerance. These data indicate that LF may be a promising agent that warrants further studies in nonhuman primate models of transplantation.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
7. |
Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis1 |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 650-656
Gary Visner,
Fuhua Lu,
Hailan Zhou,
Christopher Latham,
Anupam Agarwal,
Dani Zander,
Preview
|
PDF (1519KB)
|
|
摘要:
Background.Heme oxygenase (HO)-1, long believed to be a cytoprotective protein, has recently been identified as a graft survival gene. This study evaluates the role of HO-1 in a murine heterotopic tracheal allograft model for obliterative bronchiolitis.Methods.Mice with deficient or experimentally enhanced HO-1 expression underwent subcutaneous implantation of murine tracheal isografts and allografts. Grafts were excised after 9, 16, or 21 days and evaluated by histologic examination, immunohistochemistry for HO-1 and interleukin (IL)-10 proteins, and terminal deoxynucleotide transferase-mediated dUTP nick-end labeling. To evaluate the relationships between IL-10 and HO-1, the effects of modulation of HO-1 expression on IL-10 expression were evaluated and HO-1 expression was examined in tracheal transplants from IL-10 null mice.Results.Isografts demonstrated normal histology with minimal HO-1 staining, whereas allografts showed features of human airway rejection (loss of respiratory epithelium, luminal granulation tissue, lymphocytic tracheitis) with increased HO-1 staining in macrophages and mesenchymal cells. HO-1–deficient mice demonstrated a more rapid progression of the tracheal allograft injury as compared with control allografts, and this was associated with a decrease in the anti-inflammatory cytokine, IL-10. Tracheal transplants using IL-10–deficient mice also resulted in a more severe injury, and this was accompanied by a decrease in HO-1 staining.Conclusions.HO-1 protein expression is increased in murine heterotopic airway rejection, and deficiency of HO-1 accelerates the development of the obliterative bronchiolitis-like lesion. IL-10 protein expression parallels expression of HO-1, suggesting that IL-10 may participate in the genesis of HO-1’s effects on the inflammatory processes triggered by allotransplantation.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
8. |
Importance of hyperglycemia on the primary function of allogeneic islet transplants1 |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 657-664
Leila Makhlouf,
Valérie Duvivier-Kali,
Susan Bonner-Weir,
Hans Dieperink,
Gordon Weir,
Mohamed Sayegh,
Preview
|
PDF (542KB)
|
|
摘要:
Background.Hyperglycemia has been shown to influence primary function of islet isografts. In this study, we investigated the influence of hyperglycemia on primary function of allogeneic islets transplanted into spontaneously diabetic recipients (NOD) or streptozotocin-induced diabetic mice (BALB/c).Methods.Mice with moderate, severe, or very severe hyperglycemia underwent transplantation with a marginal number of islets (350 into BALB/c mice and 700 into NOD mice). To prevent the alloimmune response, we used blockade of CD28:B7 and CD40L:CD40 costimulatory signaling pathways to determine the effect of hyperglycemia alone. Blood glucose levels of the mice were monitored after transplantation, and the grafts were assessed morphologically.Results.Transplantation of allogeneic islets into moderately hyperglycemic BALB/c mice or severely diabetic NOD mice normalized the blood glucose levels in all mice within 3 days after transplantation, demonstrating the primary function of the graft. However, primary nonfunction was observed in all animals when islet transplantation was performed into severely diabetic BALB/c mice or very severely diabetic NOD mice. When mice were treated with costimulation blockade, reversal of diabetes was observed in severely diabetic BALB/c mice 15 days after transplantation, showing that the islets could adapt to the environment and function. However, transplantation of islets into NOD mice with very severe diabetes treated with costimulation blockade did not reverse diabetes, showing that even in the absence of alloimmune responses and given an adaptation period, the islets could not function.Conclusions.This study demonstrates that severe hyperglycemia impairs islet allograft function in BALB/c and NOD mice and that successful islet allotransplantation depends on the degree of hyperglycemia in the recipient.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
9. |
Coadministration of tacrolimus with anti-acid drugs |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 665-666
Marie Chisholm,
Laura Mulloy,
Muralidharan Jagadeesan,
Joseph DiPiro,
Preview
|
PDF (91KB)
|
|
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
10. |
Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation1 |
|
Transplantation,
Volume 76,
Issue 4,
2003,
Page 667-673
K. Topp,
P. Painter,
S. Walcott,
J. Krasnoff,
D. Adey,
G. Sakkas,
J. Taylor,
K. McCormick,
M. teNyenhuis,
M. Iofina,
S. Tomlanovich,
P. Stock,
Preview
|
PDF (1000KB)
|
|
摘要:
Background.Limitations in exercise capacity in kidney transplant recipients are thought to result in part from changes in muscle structure and function associated with immunosuppression therapy.Methods.We compared the percent distribution of skeletal muscle fiber types, cross-sectional areas, and ultrastructural morphologies in kidney transplant recipients treated with standard prednisone maintenance therapy (n=21) to those undergoing rapid withdrawal of prednisone using Simulect (interleukin 2 receptor inhibitor) (n=13). Skeletal muscle biopsy specimens from the vastus lateralis were analyzed at 3 and 12 months after transplantation and compared with sedentary controls (n=15).Results.Compared with the control group, the group receiving prednisone maintenance therapy had a significantly lower percentage of type I fibers and a higher percentage of type IIB/x fibers, evident at 3 and 12 months. Fiber type distribution in patients withdrawn from prednisone did not differ from controls. In patients withdrawn from prednisone, the cross-sectional areas of type I and IIA fibers were lower and the area of type IIB/x fibers was higher compared with controls. Likewise, ultrastructural studies revealed reduced volume densities of myofibrils and higher densities of interfibrillar and subsarcolemmal mitochondria. At 12 months there were no ultrastructural differences between the patients withdrawn from prednisone and controls.Conclusions.We conclude that prednisone maintenance therapy contributes to the lower exercise capacity by altering the ratio of type I to type IIB/x fibers and by reducing myofilament density. The increase in mitochondria in patients receiving prednisone may reflect a switch from carbohydrate to lipid metabolism resulting from the glucocorticoid therapy.
ISSN:0041-1337
出版商:OVID
年代:2003
数据来源: OVID
|
|